Edition:
United States

NeuroMetrix Inc (NURO.OQ)

NURO.OQ on NASDAQ Stock Exchange Capital Market

1.27USD
20 Jul 2018
Change (% chg)

$0.00 (+0.00%)
Prev Close
$1.27
Open
$1.26
Day's High
$1.28
Day's Low
$1.26
Volume
5,570
Avg. Vol
28,499
52-wk High
$2.96
52-wk Low
$1.20

Chart for

About

NeuroMetrix, Inc. is a healthcare company combining bioelectrical and digital medicine to address chronic health conditions, including chronic pain, sleep disorders and diabetes. The Company is engaged in the sale of medical equipment, and consumables and accessories. It has two principal product lines: Wearable neuro-stimulatio... (more)
No analyst recommendations are available for .

Overall

Beta: 0.37
Market Cap(Mil.): $10.67
Shares Outstanding(Mil.): 7.36
Dividend: --
Yield (%): --

Financials

  NURO.OQ Industry Sector
P/E (TTM): -- 43.60 33.05
EPS (TTM): -6.69 -- --
ROI: -113.97 14.53 13.17
ROE: -153.92 17.67 15.10

BRIEF-NeuroMetrix Q1 Revenue Rose 15 Percent To $4.9 Million

* QTRLY NET INCOME WAS $1.2 MILLION IN COMPARISON WITH A NET LOSS OF $3.2 MILLION IN Q1 2017 Source text for Eikon: Further company coverage:

Apr 19 2018

BRIEF-Schrole Group Says Entered Alliance With International School Services, Inc​

* ‍ENTERS STRATEGIC ALLIANCE WITH INTERNATIONAL SCHOOL SERVICES, INC​ Source text for Eikon: Further company coverage:

Apr 04 2018

BRIEF-Neurometrix Inc Says Net Loss Was About $2.9 Mln In Q4 2017 Compared To $2.8 Mln In Q4 2016

* NEUROMETRIX REPORTS Q4 AND FULL YEAR 2017 FINANCIAL RESULTS

Jan 25 2018

Competitors

  Price Chg
Natus Medical Inc (BABY.OQ) $32.75 +0.20

Earnings vs. Estimates